CVS Health Corporation (CVS)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CVS Health Corporation (CVS) trades at $73.02 with AI Score 47/100 (Weak). CVS Health Corporation is a leading healthcare company providing a wide array of health services, including pharmacy benefit management, retail pharmacy, and health insurance products. Market cap: $92.90B, Sector: Healthcare.
Last analyzed: Feb 8, 2026CVS Health Corporation (CVS) Healthcare & Pipeline Overview
CVS Health Corporation delivers integrated healthcare solutions through its pharmacy services, retail locations, and health insurance plans, leveraging its extensive network and innovative services to improve patient outcomes and drive shareholder value with a 3.40% dividend yield and a beta of 0.50.
Investment Thesis
CVS Health presents a notable research candidate due to its integrated healthcare model and strategic positioning within the growing healthcare market. The company's diverse revenue streams, spanning pharmacy services, retail healthcare, and health insurance, provide resilience and growth potential. CVS's MinuteClinics and Health Care Benefits segment offer significant expansion opportunities, driven by increasing demand for accessible and affordable healthcare. With a dividend yield of 3.40%, CVS offers an attractive income stream for investors. Key value drivers include the company's ability to manage healthcare costs, improve patient outcomes, and expand its digital healthcare offerings. While the company's profit margin is currently at 0.1%, strategic initiatives aimed at improving operational efficiency and expanding higher-margin services are expected to drive profitability improvements in the coming years. The company's low beta of 0.50 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates approximately 9,900 retail locations and 1,200 MinuteClinic locations as of December 31, 2021, providing extensive access to healthcare services.
- Offers a dividend yield of 3.40%, providing an attractive income stream for investors.
- The company has a beta of 0.50, indicating lower volatility compared to the broader market.
- Serves a diverse range of clients, including employer groups, individuals, and government entities, through its Health Care Benefits segment.
- Provides pharmacy benefit management (PBM) solutions, including formulary management and specialty pharmacy services, through its Pharmacy Services segment.
Competitors & Peers
Strengths
- Large and established network of retail pharmacies and MinuteClinics.
- Integrated healthcare model with pharmacy services, retail healthcare, and health insurance.
- Strong brand recognition and customer loyalty.
- Expertise in pharmacy benefit management (PBM).
Weaknesses
- Low profit margin of 0.1%.
- Exposure to regulatory changes and healthcare policy risks.
- Dependence on prescription drug sales.
- Competition from other healthcare providers and retailers.
Catalysts
- Expansion of MinuteClinic services and digital health initiatives to drive revenue growth and improve patient outcomes.
- Growth in the pharmacy services segment and specialty pharmacy market, driven by increasing demand for cost-effective prescription drug management.
- Potential strategic partnerships and acquisitions to expand capabilities and market reach in the healthcare industry.
- Increasing demand for accessible and affordable healthcare, creating opportunities for CVS to expand its services and customer base.
Risks
- Increasing competition from online pharmacies and retailers could erode market share and pressure prices.
- Rising healthcare costs and pressure to reduce prices could negatively impact profitability.
- Regulatory changes and healthcare policy risks could impact CVS's business model and operations.
- Economic downturn and reduced consumer spending could negatively impact sales and profitability.
- Litigation and legal challenges related to pharmacy practices and healthcare services.
Growth Opportunities
- Expansion of MinuteClinic Services: CVS has the opportunity to expand its MinuteClinic footprint and service offerings. The market for convenient, walk-in medical care is growing, driven by increasing demand for accessible and affordable healthcare. By expanding its MinuteClinic network and offering a wider range of services, CVS can attract new customers and increase revenue. This expansion aligns with the trend towards value-based care and the growing demand for convenient healthcare access. The market size for walk-in clinics is projected to reach $40 billion by 2028, presenting a significant growth opportunity for CVS.
- Growth in Pharmacy Services Segment: The Pharmacy Services segment offers significant growth potential through expanding its PBM solutions and specialty pharmacy services. The market for PBM services is growing, driven by increasing demand for cost-effective prescription drug management. By expanding its PBM offerings and leveraging its scale, CVS can attract new clients and increase revenue. The specialty pharmacy market is also growing rapidly, driven by the increasing prevalence of chronic diseases and the development of new specialty drugs. CVS can capitalize on this trend by expanding its specialty pharmacy services and offerings.
- Digital Health Initiatives: CVS can leverage digital health technologies to enhance its services and improve patient outcomes. The market for digital health solutions is growing rapidly, driven by increasing adoption of telehealth, mobile health apps, and wearable devices. By investing in digital health initiatives, CVS can improve patient engagement, enhance access to care, and reduce healthcare costs. This includes expanding its telehealth services, developing mobile health apps, and integrating wearable devices into its care management programs. The digital health market is projected to reach $660 billion by 2027, presenting a significant growth opportunity for CVS.
- Expansion of Health Care Benefits Segment: The Health Care Benefits segment offers growth opportunities through expanding its health insurance products and services. The market for health insurance is growing, driven by increasing healthcare costs and the aging population. By expanding its health insurance offerings and leveraging its integrated model, CVS can attract new members and increase revenue. This includes offering a wider range of health insurance plans, expanding its Medicare and Medicaid offerings, and partnering with healthcare providers to improve care coordination. The health insurance market is projected to reach $1.5 trillion by 2028, presenting a significant growth opportunity for CVS.
- Strategic Partnerships and Acquisitions: CVS can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with healthcare providers, technology companies, and other healthcare organizations to enhance its services and improve patient outcomes. CVS can also pursue acquisitions to expand its geographic reach, enter new markets, and acquire new technologies. Strategic partnerships and acquisitions can help CVS accelerate its growth and strengthen its competitive position in the healthcare industry.
Opportunities
- Expansion of MinuteClinic services and digital health initiatives.
- Growth in the pharmacy services segment and specialty pharmacy market.
- Strategic partnerships and acquisitions to expand capabilities and market reach.
- Increasing demand for accessible and affordable healthcare.
Threats
- Increasing competition from online pharmacies and retailers.
- Rising healthcare costs and pressure to reduce prices.
- Regulatory changes and healthcare policy risks.
- Economic downturn and reduced consumer spending.
Competitive Advantages
- Scale and scope: CVS has a vast network of retail pharmacies and MinuteClinics, providing convenient access to healthcare services for millions of customers.
- Integrated model: CVS's integrated model, combining pharmacy services, retail healthcare, and health insurance, allows it to manage costs, improve patient outcomes, and enhance access to healthcare services.
- Brand recognition: CVS is a well-known and trusted brand in the healthcare industry.
- PBM expertise: CVS has extensive expertise in pharmacy benefit management (PBM), providing cost-effective prescription drug management solutions for employers and health plans.
About CVS
Founded in 1963 and headquartered in Woonsocket, Rhode Island, CVS Health Corporation has evolved from a chain of health and beauty stores into a diversified healthcare giant. Originally known as CVS Caremark Corporation, the company rebranded to CVS Health Corporation in 2014 to reflect its broader commitment to health and well-being. CVS operates through three primary segments: Health Care Benefits, Pharmacy Services, and Retail/LTC. The Health Care Benefits segment offers a range of health insurance products, serving employer groups, individuals, and government entities. The Pharmacy Services segment provides pharmacy benefit management (PBM) solutions, including formulary management and specialty pharmacy services. The Retail/LTC segment operates approximately 9,900 retail locations and 1,200 MinuteClinic locations as of December 31, 2021, offering prescription drugs, over-the-counter medications, and consumer health products. CVS's integrated model allows it to manage costs, improve patient outcomes, and enhance access to healthcare services. The company's strategic focus on expanding its healthcare services and digital capabilities positions it for continued growth in the evolving healthcare landscape.
What They Do
- Provides pharmacy benefit management (PBM) services to employers and health plans.
- Operates retail pharmacies offering prescription and over-the-counter medications.
- Offers health insurance products and services through its Health Care Benefits segment.
- Provides healthcare services through MinuteClinic walk-in medical clinics.
- Sells consumer health and beauty products in its retail stores.
- Distributes prescription drugs to care facilities and other care settings.
- Offers specialty pharmacy services for patients with chronic conditions.
- Provides infusion and enteral nutrition services.
Business Model
- Generates revenue from pharmacy benefit management (PBM) fees.
- Generates revenue from the sale of prescription and over-the-counter medications in its retail pharmacies.
- Generates revenue from premiums and fees from its health insurance products.
- Generates revenue from providing healthcare services in its MinuteClinics.
- Generates revenue from the sale of consumer health and beauty products.
Industry Context
CVS Health operates in the dynamic and rapidly evolving healthcare industry. The market is characterized by increasing demand for accessible, affordable, and integrated healthcare solutions. Key trends include the shift towards value-based care, the growing adoption of digital health technologies, and the increasing prevalence of chronic diseases. CVS competes with other major players in the healthcare industry, including health insurance companies like ELV and CI, pharmaceutical companies like BMY and GSK, and other retail pharmacy chains. The company's integrated model, combining pharmacy services, retail healthcare, and health insurance, differentiates it from its competitors and positions it to capitalize on the growing demand for comprehensive healthcare solutions.
Key Customers
- Employers who use CVS's PBM services to manage prescription drug benefits for their employees.
- Individuals who purchase prescription and over-the-counter medications at CVS pharmacies.
- Individuals and families who enroll in CVS's health insurance plans.
- Patients who receive healthcare services at CVS MinuteClinics.
- Care facilities and other care settings that purchase prescription drugs from CVS.
Financials
Chart & Info
CVS Health Corporation (CVS) stock price: $73.02 (+0.00, +0.00%)
Latest News
-
Omnicare Signs Asset Purchase Agreement With GenieRx Holdings
benzinga · Apr 1, 2026
-
Healthcare Reclaims No. 1 Spot On Americans' List Of Worries As Financial Strain Grows
benzinga · Apr 1, 2026
-
Analyst Report: Perrigo Company plc
Morningstar Research · Mar 31, 2026
-
Elon Musk's X Loses Advertiser Boycott Lawsuit As 'Teflon Elon' Legal Streak Unravels
benzinga · Mar 26, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CVS.
Price Targets
Consensus target: $96.50
MoonshotScore
What does this score mean?
The MoonshotScore rates CVS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Omnicare Signs Asset Purchase Agreement With GenieRx Holdings
Healthcare Reclaims No. 1 Spot On Americans' List Of Worries As Financial Strain Grows
Analyst Report: Perrigo Company plc
Elon Musk's X Loses Advertiser Boycott Lawsuit As 'Teflon Elon' Legal Streak Unravels
Latest CVS Health Corporation Analysis
Common Questions About CVS (Healthcare)
What does CVS Health Corporation do?
CVS Health Corporation operates as a diversified healthcare company, providing a wide range of services through its three main segments: Health Care Benefits, Pharmacy Services, and Retail/LTC. The company provides pharmacy benefit management (PBM) services, manages health insurance plans, and operates retail pharmacies and MinuteClinics. CVS aims to provide accessible and affordable healthcare solutions to individuals, employers, and government entities. The company's integrated model allows it to manage costs, improve patient outcomes, and enhance access to healthcare services, positioning it as a key player in the evolving healthcare landscape.
Is CVS stock worth researching?
CVS stock presents a mixed investment case. The company's integrated healthcare model and diverse revenue streams provide resilience and growth potential. The dividend yield of 3.40% offers an attractive income stream. However, the low profit margin of 0.1% raises concerns about profitability. Investors may want to evaluate the company's growth opportunities, such as expanding MinuteClinic services and digital health initiatives, as well as the potential risks, such as increasing competition and regulatory changes. A balanced analysis of these factors is crucial in determining whether CVS stock is worth researching.
What are the main risks for CVS?
CVS faces several key risks, including increasing competition from online pharmacies and retailers, rising healthcare costs and pressure to reduce prices, regulatory changes and healthcare policy risks, and potential economic downturns. The company's dependence on prescription drug sales also poses a risk, as changes in drug pricing and reimbursement policies could impact revenue. Additionally, CVS faces potential litigation and legal challenges related to pharmacy practices and healthcare services. These risks could negatively impact CVS's financial performance and competitive position.
What are the key factors to evaluate for CVS?
CVS Health Corporation (CVS) currently holds an AI score of 47/100, indicating low score. The stock trades at a P/E of 53.3x, above the S&P 500 average (~20-25x), suggesting high growth expectations. Analysts target $96.50 (+32% from $73.02). Key strength: Large and established network of retail pharmacies and MinuteClinics. Primary risk to monitor: Increasing competition from online pharmacies and retailers could erode market share and pressure prices. This is not financial advice.
How frequently does CVS data refresh on this page?
CVS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CVS's recent stock price performance?
Recent price movement in CVS Health Corporation (CVS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $96.50 implies 32% upside from here. Notable catalyst: Large and established network of retail pharmacies and MinuteClinics. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CVS overvalued or undervalued right now?
Determining whether CVS Health Corporation (CVS) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 53.3. Analysts target $96.50 (+32% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CVS?
Before investing in CVS Health Corporation (CVS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Stock data pending update.
- Financial metrics based on the most recent available data.